Back

Effectiveness and safety of rivaroxaban versus warfarin in nonvalvular atrial fibrillation patients with coronary or peripheral artery disease

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 4 Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Craig Coleman

University of Connecticut, Storrs (United States of America)

8 More presentations in this session

Presentation thumbnail
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
Doctor P. Rasmussen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Professor J. Hartikainen (Kuopio, FI)
Abstract Slides
Presentation thumbnail
Associate Professor S. Choi (Daegu, KR)
Abstract Slides
Presentation thumbnail
Doctor G. Vanerio (Montevideo, UY)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 4

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources